fMRI as an outcome measure in clinical trials: A systematic review in clinicaltrials.gov
Alaleh Sadraee, Martin P. Paulus, Hamed Ekhtiari
doi: https://doi.org/10.1101/19002972
Alaleh Sadraee
aInstitute for Cognitive Science Studies, Tehran, Iran
bIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
Martin P. Paulus
cLaureate Institute for Brain Research, Tulsa, OK, United States of America
Hamed Ekhtiari
cLaureate Institute for Brain Research, Tulsa, OK, United States of America
Article usage
Posted July 25, 2019.
fMRI as an outcome measure in clinical trials: A systematic review in clinicaltrials.gov
Alaleh Sadraee, Martin P. Paulus, Hamed Ekhtiari
medRxiv 19002972; doi: https://doi.org/10.1101/19002972
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)